Skip to content

Oxygenation of Affected Limbs in CRPS-I Patients

Oxygenation of Affected Limbs in CRPS-I Patients - Oxygenation in CRPS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43069
Enrollment
30
Registered
2016-05-20
Start date
2016-09-19
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regionaal Pijn Syndroom nerve pain post traumatic dystrophy

Interventions

Oxygen is applied as an intervention to examine and compare its effect on the oxygenation in healthy participants and CRPS patients.

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria CRPS-I patients: CRPS-I according to 2012 IASP (Budapest) criteria: Harden RN, Bruehl S, Perez RS, et al. Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain 2010; 150: 268-274.;Inclusion criteria pain controls: Patients diagnosed with Radiculopathy with pain in one extremity as main symptom;Inclusion criteria healthy controls: >18 years old, healthy (no neurological, cardiac, pulmonary, renal or vascular diseases diagnosed)

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study:;- Age

Design outcomes

Primary

MeasureTime frame
Tissue oxygenation in both static and dynamic conditions will be compared between CRPS-affected and unaffected limbs and between CRPS patients, pain controls and healthy controls. Furthermore, differences in tissue oxygenation in static and dynamic measurements and correlations with pain, skin temperature variations, and disease duration will be determined.

Secondary

MeasureTime frame
The correlation between oxygenation and skin temperature with experienced pain, amount of limb movement, and disease duration will be investigated as well.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)